Tucker Coston Selected Research

Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)

1/2019

Suboptimal response rates to hypomethylating agent therapy in chronic myelomonocytic leukemia; a single institutional study of 121 patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tucker Coston Research Topics

Disease

2	Neoplasms (Cancer) 01/2023 - 01/2019
1	Fibrosis (Cirrhosis) 12/2023
1	Hepatocellular Carcinoma (Hepatoma) 12/2023
1	Neoplasm Metastasis (Metastasis) 12/2023
1	Microsatellite Instability 01/2023
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023
1	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2019
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2019

Drug/Important Bio-Agent (IBA)

1	Immune Checkpoint InhibitorsIBA 01/2023
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	pembrolizumabIBA 01/2023
1	Azacitidine (5 Azacytidine)FDA Link 01/2019
1	Decitabine FDA Link 01/2019

Therapy/Procedure

2	Therapeutics 01/2023 - 01/2019
1	Liver Transplantation 12/2023
1	Transplantation 12/2023
1	Drug Therapy (Chemotherapy) 01/2023